Progen Biotechnik GmbH

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Progen Biotechnik GmbH - overview

Location

Heidelberg, -, Germany

Primary Industry

Biotechnology

About

Progen develops, produces and markets tests for patient glucose testing, infectious diseases and products for biomedical research.


Primary Industry

Biotechnology

Sub Industries

Biotechnology

Website

www.progen.de

Verticals

HealthTech

Total Amount Raised

Subscriber access only

Progen Biotechnik GmbH - financials

Fiscal Year EndedDec 31, 2006Dec 31, 2007Dec 31, 2008Dec 31, 2009Dec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015
Revenue (USD)8,780,449.2---------
% Revenue Growth (YoY)----------
EBITDA (USD)(1,802,533.6)---------
Operating Income (USD)(2,242,786)---------
Operating Margin(25.5%)---------
% EBITDA Margin(20.5%)---------
NET Income (USD)738,353.8(787,346.6)2,653-875,197.2(639,862.9)198,603.4---
% Net Margin8.4%---------

Progen Biotechnik GmbH - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedProgen Biotechnik GmbH-
Unspecified ExitCompletedProgen Biotechnik GmbH-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.